Cargando…
Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma
CONTEXT: The diagnosis of papillary thyroid carcinoma (PTC) is based on nuclear features. These features may be present in focal areas in benign thyroid diseases and follicular adenoma (FA), leading to diagnostic difficulty. AIMS: To evaluate the expression and pattern of the distribution of cytoker...
Autores principales: | Bose, Debdas, Das, Ram Narayan, Chatterjee, Uttara, Banerjee, Uma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3439787/ https://www.ncbi.nlm.nih.gov/pubmed/22988353 http://dx.doi.org/10.4103/0971-5851.99746 |
Ejemplares similares
-
CD56, HBME-1 and cytokeratin 19 expressions in papillary thyroid carcinoma and nodular thyroid lesions
por: Erdogan-Durmus, Senay, et al.
Publicado: (2016) -
Scoring System and Diagnosis of Papillary Thyroid Carcinoma Using Human Bone Marrow Endothelium Marker-1, Cytokeratin 19, and Galectin-3
por: Asghari, Abolfazl, et al.
Publicado: (2023) -
Immunoexpression of HBME-1, High Molecular Weight Cytokeratin, Cytokeratin 19, Thyroid Transcription Factor-1, and E-cadherin in Thyroid Carcinomas
por: Choi, Yoon-La, et al.
Publicado: (2005) -
Nuclear Localization of Immunoreactive β‐Catenin Is Specific to Familial Adenomatous Polyposis in Papillary Thyroid Carcinoma
por: Kurihara, Katsumi, et al.
Publicado: (2000) -
An analysis of Cyclin D1, Cytokeratin 5/6 and Cytokeratin 8/18 expression in breast papillomas and papillary carcinomas
por: Wang, Yu, et al.
Publicado: (2013)